Form 4 · Filed Jun 11, 2026, 08:07 PM UTC
LYEL/Lyell Immunopharma, Inc.
Shook David — Chief Medical Officer
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
1 row| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 10, 2026 | S | sell | 1,977 | $13 | $24,989 | 20,923 |
Source: SEC EDGAR raw filing ↗ · Accession 0001959742-26-000002